HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice
Highest dose, obesity trial obesity-plus-diabetes trial (treatment-policy estimand): Semaglutide: 14.9% (STEP 1) 9.6% (STEP 2), a 5.3 point gap Tirzepatide: 20.9% (SURMOUNT-1) 14.7% (SURMOUNT-2), a 6.2 point gap Retatrutide: 25.0% (TRIUMPH-1) 20.8% (TRIUMPH-2 only efficacy-estimand currently reported so true gap is larger) It's still unclear the reason why we observe less weight loss in those with type 2 diabetes
About the Company OrderlyMeds is a telehealth-based weight loss platform founded in January 2024 and headquartered in Decatur, Georgia, offering both compounded and brand-name GLP-1 medications and positioning itself as one of the more affordable entry points in the market
The growing recognition of proximity in urban planning as a key factor in creating livable and resilient cities is evident in some initiatives such as the Global Observatory of Sustainable Proximities, a capacity-building platform launched to support 'proximity' in urban planning supported by the UN (GOSP, 2025)